Envista Holdings Corporation (NVST)
Is Envista (NVST) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
NVST or LZAGY: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Products sector have probably already heard of Envista (NVST) and Lonza Group Ag (LZAGY). But which of these two stocks presents investors with the better value opportunity right now?
Reasons to Retain Envista Stock in Your Portfolio for Now
NVST's Specialty Products and Technologies business' strong performance appears promising. Yet, a leveraged balance sheet is worrisome.
Deciphering Envista (NVST) International Revenue Trends
Evaluate Envista's (NVST) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Envista Stock Climbs on Q3 Earnings and Revenue Beat, Margins Crash
NVST delivers better-than-expected top and bottom-line performance in the third quarter of 2024.
Envista Holdings Corporation (NVST) Q3 2024 Earnings Conference Call Transcript
Envista Holdings Corporation (NYSE:NVST ) Q3 2024 Earnings Conference Call October 30, 2024 5:00 PM ET Company Participants Amit Bhagwat - VP of IR Paul Keel - CEO Eric Hammes - CFO Conference Call Participants Elizabeth Anderson - Evercore ISI Jeff Johnson - Robert W. Baird & Co. Erin Wright - Morgan Stanley & Co. Jon Block - Stifel, Nicolaus & Company Michael Cherney - Leerink Partners Kevin Caliendo - UBS Securities Brandon Vazquez - William Blair & Company Vivek Chopra - Wells Fargo Operator My name is David and I'll be your conference facilitator this afternoon.
Compared to Estimates, Envista (NVST) Q3 Earnings: A Look at Key Metrics
Although the revenue and EPS for Envista (NVST) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Envista (NVST) Q3 Earnings and Revenues Beat Estimates
Envista (NVST) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.43 per share a year ago.
Earnings Preview: Envista (NVST) Q3 Earnings Expected to Decline
Envista (NVST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Envista: $1.2 Billion Asset Impairments Was Fully Priced In
Envista Holdings Corporation published Q2 2024 earnings results, highlighting a $1.2 billion non-cash charge from impairments. I find their valuation metrics quite attractive, comparing favorably to both the healthcare sector and their 5-year historical averages. Despite recent challenges, the company continues to generate positive free cash flows.
Why Envista (NVST) International Revenue Trends Deserve Your Attention
Examine Envista's (NVST) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
Envista (NVST) Q2 Earnings & Revenues Miss, Margins Fall
Envista's (NVST) Spark division sales witness a slowdown in the second quarter due to the deferment of a larger portion of case revenues.
